| Literature DB >> 34806194 |
Robin E Ferner1, Julie Mason2, Hannah K Vallance2, Tanvi Choudhary2, John F Marriott2, Jamie J Coleman1, Sarah K Pontefract2.
Abstract
In response to the COVID-19 pandemic, Health Education England (HEE) and the University of Birmingham provided National Health Service (NHS) staff free access to SCRIPT, a national eLearning programme for safer prescribing and therapeutics. The eLearning was particularly for those returning to work or being redeployed. In the year March 2020-21, 3412 users registered to access portfolios and opened an aggregate of 17 198 modules. Each user completed a median of 2 (range 1-50, interquartile range [IQR] 1-7) assessed learning modules. Marks improved from pre-test to post-test by a median of 2 (IQR 0-3) marks out of 10. The most frequently selected modules were Adherence and Concordance (1109 users), Fluids (981 users) and Diabetic Emergencies (818 users). A total of 878 users accessed the unassessed COVID-19 module. The SCRIPT modules provided standardised education in core principles relating to prescribing and therapeutics, and were used by professionals from many healthcare disciplines.Entities:
Keywords: COVID-19; drug prescriptions; drug therapy; education; health professionals; internet; learning
Mesh:
Year: 2021 PMID: 34806194 PMCID: PMC9011708 DOI: 10.1111/bcp.15153
Source DB: PubMed Journal: Br J Clin Pharmacol ISSN: 0306-5251 Impact factor: 4.335
FIGURE 1Number of modules attempted by each of the 1387 learners who completed at least one module
FIGURE 2Total number of modules completed by month from 24 March 2020 to 31 March 2021
The 10 most widely used modules by the number of learners, with mean improvements in score between pre‐ and post‐test results
| Module | Number of learners | Average time spent on module (minutes) | Mean improvement in score (post‐test − pre‐test) |
|---|---|---|---|
| Adherence and concordance | 1109 | 32.9 | 0.6 |
| Fluids | 981 | 61.3 | 2.2 |
| COVID‐19 | 878 | 48.4 |
|
| Diabetic emergencies | 818 | 42.7 | 2.2 |
| Cardiac arrest | 743 | 41.1 | 1.9 |
| Drug allergy and anaphylaxis | 695 | 61.6 | 2.6 |
| Anticoagulation, Part 1 | 681 | 45.7 | 1.8 |
| Taking a safe and effective drug history | 650 | 49.9 | 0.7 |
| Sepsis in hospital | 611 | 38.4 | 1.8 |
| Dosing and calculation | 589 | 57.2 | 1.0 |
Based on those users who completed both pre‐ and post‐test. The maximum score for each test was 10 marks.
There was no score associated with the COVID‐19 module.